Editorial Policies and Publication Ethics
Following the initiatives of different scholarly regulatory organizations (such as Committee on Publication Ethics (COPE), the Directory of Open Access Journals (DOAJ), the Open Access Scholarly Publishers Association (OASPA), International Committee of Medical Journal Editors (ICMJE) and American Medical Association (AMA)) which have made painstaking attempts to identify and set standards for publication misconduct have created a new era in the domain of scholarly publishing.
Openventio values the efforts of the aforementioned reputed scholarly organizations and aims to commit towards the maintenance of the highest scientific and ethical standards by adhering to and following the best publishing practices.
With the objective to maintain the integrity of our publications, Openventio pledges the following general guiding principles;
• Committing to academic freedom, and the right to publish;
• Maintaining the high standards and quality of research by committing to scientific openness, integrity and ethics;
• Promoting recognized best practices and standards in research across multiple disciplines, and adopting and creating awareness on emerging practices and standards;
• Publish novel models, and promote advocacy, education and innovative content;
• Effective dissemination of research results, and advancing the trends of publishing technology.
According to the International Committee of Medical Journal Editors (ICMJE), the credit for authorship should be based on the following:
• Substantial contributions to the conception or design of the work, or the acquisition, analysis or interpretation of data for the work;
• Drafting the work or revising it critically for the development of important intellectual content;
• Final approval of the revision to be published;
• Agreement to be accountable for all aspects of the work by ensuring that questions related to the accuracy or integrity of any part of the work is appropriately investigated and resolved.
In addition to this, an author should also be able to identify the co-authors contributing towards other specific parts of the manuscript. Therefore, the authors should have the confidence of their co-authors in maintaining the integrity of their contribution towards the study.
Those who meet the above 4 requisite criteria are designated as the authors and the ones who do not meet the requirements of the above criteria but indirectly assist the authors in the production of the study should be recognized in the acknowledgements section of the manuscript.
Manuscript Categories & FormatsManuscript Categories
Brief Research Report
Research Clinical Trials Protocol
Letter to the Editor (related to case study/series)
Letter to the Editor
*Kindly refer Summary of Manuscript Types and Formats below for details on abstract, manuscript length, no. of figures and tables.
• Main body of the text should be separated using subheadings (e.g., "Materials and Methods," "Results," and "Discussion").
• Should be supported by significant and relevant amount of data.
• Data should have been developed by the author(s) and the conclusions must comply with the presented data.
• Relevant illustrations, charts and tables must be included.
Brief Research Report
• Format of manuscript preparation is similar to that of original research.
• Research that is in early stages of development or those conducted on a small scale.
• These may include preliminary studies that utilize a simple research design or a small sample size, and that have generated limited pilot data and initial findings that indicate the need for further investigation.
• Project summary/abstract is a must.
• General information such as the Protocol title, protocol identifying number and date, Name and address of the sponsor/funder, Name and title of the investigator conducting the research, name, address and telephone number(s) of the research site(s), clinical laboratory, medical and/or technical department(s) and/or institutions involved in the research, as well as responsibilities of each of the investigators.
• Background information and significance, objective, study design, methods, safety considerations, follow-up, data management, statistics, quality assurance, expected outcome, results, duration, ethic and consent should be included.
Research Clinical Trial Protocol
• Similar format to that of research protocol.
• However, the protocol for the trial must follow the ICH Good Clinical Practice guidelines.
• Letters reporting cases, outbreaks, or original research.
• Authors should provide a short abstract, references, and a short biographical sketch; however, it must not be divided into sections.
• Format of manuscript preparation is similar to that of original research.
• Relevant illustrations, charts and tables must be included.
• Statistics and conclusions must comply with the research data used.
• Participants must be pre-informed about the research study.
• Topic should be of interest to a wide readership.
• Topic should be discussed in an understandable and lucid language.
• Structured abstract must be included.
• Figures and tables must be included where necessary.
• Should not contain original data.
• Significant number of references should be used and cited.
• Format of manuscript preparation is similar to that of a review manuscript.
• Recently published book reviews on subjects significant to the journal are welcome.
• The title, author(s), publisher, number of pages, ISBN number (if applicable) and other relevant details should be included.
• Format of manuscript preparation is similar to that of review manuscript.
• Topic should be discussed in an understandable and lucid language.
• Figures and tables must be included where necessary.
• Should not contain original data.
• Significant number of references should be used and cited.
• It should be structured in the following format: structured abstract, introduction, methods/materials, conclusion and discussion.
• Materials and methods should also include inclusion and exclusion criteria, key words used, identification of studies, study selection, data extraction and quality assessment.
• In data analysis, statistical tools used should be mentioned along with their names and version supported by a table of comparisons.
• Unstructured abstract must be included.
• Subheadings are recommended (eg. abstract, overview, case report, discussion, conclusion, competing interests, consent, references).
• The report must provide an original description of previously unreported entity or report new presentation of a known disease.
• Must be accompanied by clinical, radiological and pathological images.
• Images may include clinical images, radiology images (USG, CT, MRI, PET, and SPECT, etc.), pathology images (histopathology, cytopathology, hematopathology) or a series of images of a clinical procedure or event.
• Should include a consent statement of the patient.
• Unstructured abstract must be included.
• Subheadings are recommended (eg. abstract, overview, case series, discussion, conclusion, competing interests, consent, references).
• Should report a series of similar cases.
• Case series must be accompanied with a comprehensive review of literature.
• Should describe a particular technology, surgical techniques, new instruments, technical innovations and their applications.
• Must contain original data to support the development of a related technology or application.
Letter to the Editor
• Can be in support of a research or case report.
• Should support, refute, or add pertinent information related to a previously published manuscript.
• Authors may also send letters to amend their previous work.
• The letter should not be divided into sections.
• Typically shorter than two pages.
• Must be precise and should attempt to conclude all the arguments made in the beginning of the text, without separating the editorial into sections.
• Discussions, critical suggestions on current topics.
• Although no abstract, figures, or tables are required, references can be included.
• It can be the author’s suggestion, reviewer’s recommendation or the reader’s comments.
• Should be written in a clear and concise language along with a structured abstract.
• Statement made by the researchers must be clearly mentioned in the beginning of the manuscript.
• The hypothesis must be testable and realistic.
• Must be verifiable by statistical and analytical means, to support the verification or falsification of the reported findings.
• Opinion on an ongoing or published research, matters of public welfare or social interest, can be included depending upon the scope of the journal.
• Following a particular format is not required.
• Similar to opinion.
• If detailed methods are included, a separate section on experimental procedures should immediately follow the body of the text.
• Includes new ideas, controversial opinions, negative results and suggestions.
• The subject must be original and scientifically significant.
• Can be used to communicate errors that need to be appended to a book or published manuscript.
• A statement addressing the error and its correction should be included.
• Can include clinical images, diagnostic or investigative images in radiology, endoscopy, pathology and cytopathology.
• A brief history, case discussion and conclusion should be included.
• Papers presented in a conference are usually accepted.
• Illustrations, references, and links to full reports of the conference activities must be provided.
• The paper must not have been published elsewhere as a research manuscript.
• Announcements for conferences, workshops, meetings, seminars, symposia, courses, research or technical assistance.
• Date of the event, the location, the sponsoring organization(s), and website providing detailed information must be provided.
• Must be accompanied by name, address and email of the contact person.
Summary of Manuscript Types and Formats
Title and Subtitle
The title should contain no more than 25-28 words. Kindly avoid abbreviations and formulae wherever possible. Subtitles should be separated from the title by a “:”. Manuscript length may vary according to its type (refer Manuscript Formats section).
Extensive use of footnotes is discouraged. Footnotes should be confined to providing URLs, affiliations, or other truly peripheral information, and should not be used for discussions, figures, tables, and the bibliographic details of a reference, or expansions on the text. Text footnotes should be numbered consecutively, starting with those on the title page.
Abstract and Keywords
The abstract should be informative and completely self-explanatory. The abstract should state briefly the purpose of the research, the principal results and major conclusions. The abstract should summarize the manuscript content in about 250-300 words. A list of keywords (3-10) and abbreviations should be included following the abstract.
Note: For research or any study/investigative type of manuscripts, it is recommended that a structured abstract be included. Abbreviations should be accessible to a broad scientific audience.
Authors can include the following subheadings to divide the sections of their manuscript into: introduction, materials and methods, results, discussion and conclusion.
Describe the procedures in detail so that the work can be used for the purpose of further reference. Trade/brand names should be identified by an initial capital letter with the remainder of the name in lowercase. Names of suppliers of uncommon reagents or instruments should be provided along with the manufacturing location.
Openventio follows and recommends our authors to use AMA Style of referencing. The references can be cited from online or print published/in-press papers, part of an issue, complete special or theme issue, supplements, abstracts taken from sources, online or printed books, online or printed newspapers, websites, personal communication, audio tapes, video tapes, DVDs, theses or dissertation, package inserts, conference proceedings or presentations, software, government or agency bulletins, government reports. References should be cited numerically in accordance of their use in the text, and should be included in the main manuscript file under the References section. It is also mandatory to cite all the tables and figures in the text.
Piven EF. Increasing adherence to the diabetes regimen: An occupational therapy perspective. Diabetes Res Open J. 2014; 1(1): e1-e2.
• In case of more than 6 authors, provide the name of the first three authors followed by et al.
• If there is no author then start the references with the title.
• All the references should be arranged numerically and must match with those cited in the text.
i. Journal References Without Volume or Issue Numbers
Author 1, Author 2, Author 3, et al. . Journal short name. year: pp.
Author 1, Author 2, Author 3, et al. . Journal short name. year; Vol(issue no.): pp-pp.
ii. Parts of an Issue
Author 1, Author 2, Author 3, Author 4, Author 5, Author 6. . Journal short name. year; Vol(issue no, pt 3): pp-pp.
iii. Complete Special or Theme Issue
Robert J, Stacey RA, eds. Blindness. Ophthalmol. 2016; Vol(3, theme/special issue): pp-pp.
Author 1, Author 2, Author 3, et al. . Journal short name. year; Vol(issue)(suppl): pp-pp.
If supplement is numbered and without an issue number:
Author 1, Author 2, Author 3, et al. . Journal short name. year; Vol(suppl 4): pp-pp.
If supplement is numbered and there is an issue number:
Author 1, Author 2, Author 3, et al. . Journal short name. year; Vol(issue)(suppl 6): pp-pp.
If supplement has several parts:
Author1, Author 2, Author 3, et al. . Journal short name. year; Vol(issue)(suppl 6B): 17S-21S.
v. Abstract taken from a Source
Author 1, Author 2, Author 3, et al. . [abstract taken from Arch Ophthamol. 2004; 122(1):55-56]. Journal short name. year; Vol(issue): pp-pp.
vi. Manuscripts or Books Accepted but not yet Published
Journal article: Author 1, Author 2, Author 3, Author 4. . Journal short name. In press.
Book: Author. . Boston, MA, USA: Beacon Press. In press.
vii. Manuscript Submitted but not yet Accepted
These findings have recently been demonstrated (H. E. Mumanan, MD, unpublished data, January 2015).
viii. Personal Communication
In a conversation with H. E. Murman, MD (August 2005)…….
According to a letter from H.E. Murman, MD, in August 2005…….
Similar findings have been noted by Roberts and by H. E. Murman, MD (written communication, August 2003).
According to the manufacturer (H. R. Smith, oral communication, May 2004), the drug became available in Japan in January 2004.
ix. Audiotapes, Videotapes, DVDs (Digital video Disks)
Moyer B. On Our Own terms: Moyers on Dying [Videotape]. New York, NY, USA: Thirteen/WNET; 2000.
Ayers S. Terrorism: Medical Response [DVD]. Edgartown, MA, USA: Emergency Film Group; 2002.
Acland RD. Acland’s DVD Atlas of Human Anatomy [DVD], Philadelphia, PA, USA: Lipponcott Williams & Wilkins; 2007.
x. Theses and Dissertation
Fenster FD. Cloning and Characterization of Piccolo, a Novel Component of the Presynaptic Cytoskeletal Matrix [dissertation]. Birmingham, England: University of Alabama; 2000.
Undeman C. Fully automatic Segmentation of MRI Brain Images Using Probabilistic Diffusion and a Watershed Scale-Space Approach [master’s thesis]. Stockholm, Sweden: NADA, Royal Institute of Technology; 2001.
xi. Package Inserts
Cialis [package insert]. Indianapolis, IN, USA: Eli Lilly & Co.; 2003.
Z Stat Flu [package insert]. Oklahoma City, OK: ZymeTx Inc.; 2000.
xii. Online Conference Proceedings/Presentations
Chu H, Rosenthal M. Search engines for the World Wide Web: A comparative study and evaluation methodology. Paper presented at: American Society for Information Science 1996 Annual Conference; October 19-24, 1996; Baltimore, MD, USA. http://www.asis.org/annual-96/electronicproceedings/chu.html. Accessed February 6, 2004.
Collins F. Talk, presented at: National Human Research Protections Advisory Committee; April, 2001; Bethesda, MD, USA. http://www.hhs.gov/orph/nhrpac/mtg04-01/0409mtg.txt. Accessed February 26, 2004.
Klausner R. Statement on fiscal year 2002 president’s budget request for the National Cancer Institute before the House Subcommittee on Labor-HHS-Education Appropriations. http://cancer.gov/legis/testimony/house2002.html. Accessed February 6, 2004.
Hormone replacement therapy [Morning Edition audio]. National Public radio. August 5, 2002. http://www.npr.org/templates/story/story.php?storyld=1147833. Accessed March 4, 2004.
Wolfe W. State’s mail-order drug plan launched. Minneapolis Star Tribune. May 14, 2004: 1B.
Overbye D. A philanthropist of science seeks to be its next Nobel. New York Times. April 9, 2005: D1, D4.
Weiss R. The promise of precision prescriptions. Washington Post. June 24, 2000: A1. http://www.washingtonpost.com. Accessed October 24, 2011.
Perez-Pena R. Children in shelters hit hard by asthma.html. New York Times. Accessed March 2, 2004. http://www.nytimes.com/2004/03/02/nyregions/02asthgma.html. Accessed March 2, 2004.
International Society for Infectious Diseases. ProMED-mail Web site. http://www.promedmail.org. Accessed April 29, 2004.
Sullivan D. Major search engines and directories. SearchEngineWatch Website. http:// www.searchenginewatch.com/links/article.php/2156221. Updated April 28,2004. Accessed December 6, 2005.
Interim guidance about avian influenza A (H5N1) for US citizens living abroad. Center for Disease Control and Prevention Website. http://www.cdc.gov/travel/other/avian_flu_ig_americans_abroad_032405.htm. Updated November 18, 2005. Accessed December 6, 2005.
Sample size calculation. Grapentine co inc. http://www.grapentine.com/calculator.htm. Accessed December 6, 2005.
Recommendations for the care and maintenance of high intensity metal halide and mercury vapor lighting in schools. National Electrical Manufacturers Association. http://www.nema.oeg/stds/halide-schools.cfm#download. Accessed December 6, 2005.
Truth and reconciliation: examining human rights violations in South Africa’s health sector: submission to the Truth and Reconciliation Commission concerning the role of health professionals in gross violation of human rights. American Association of the Advancement of Science Web Site. http://shr.aaas.org/trc-med/presub.htm. Published 1997. Accessed April 30,2004.
Epi Info [computer program]. Version 3.2. Atlanta, GA, USA: Center for Disease Control and Prevention; 2004.
Intercooled STATA (for Windows) [computer program]. Version 7.0. College Station, TX, USA: StataCorp; 2000.
xvi. Government or Agency Bulletins
Same as book reference
xvii. Government Reports
Same as website reference
xviii. Entire Book
Modlin J, Jenkins P. Decision Analysis in Planning for a Polio Outbreak in the United States. San Francisco, CA, USA: Pediatric Academic Societies; 2004.
Solensky R. Drug allergy: desensitization and treatment of reactions to antibiotics and aspirin. In: Lockey P, ed. Allergens and Allergen Immunotherapy. 3rd ed. New York, NY, USA: Marcel Dekker; 2004: 585-606.
xix. Website Reference
World Health Organization Media Center. Diabetes Fact Sheet. Web site. http://www.who.int/mediacentre/factsheets/fs312/en/. 2013; Accessed February 21, 2014.
xx. Newspaper article (Online)
Pollack A. FDA approves new cystic fibrosis drug. New York Times. January 31, 2012. http://www.nytimes.com/2012/02/01/business/fda-approves-cystic-fibrosis-drug.html?ref=health. Accessed February 1, 2014.
xxi. Newspaper article (in print)
Wolf W. State’s mail-order drug plan launched. Minneapolis Star Tribune. May 14, 2004: 1B.
The table should have a simple design and should be self-explanatory. The details of the methods used in the experiments should be described in the legend instead of in the text. Authors are strongly recommended to submit the tables in .doc format. Each table should be on a separate page, numbered consecutively in Arabic numerals and provided with a heading and a legend. Each table should have a brief title above the table. Table footnotes should be provided below the table. Tables must be submitted as separate files, not embedded in the manuscript text. Publication-ready formats include Word and PDF.
All illustrations (line drawings and photographs) are classified as figures. Figures should be cited in a consecutive order in the text. The preferred file formats for photographic images are .doc, TIFF, PNG and JPEG. If the images have been created with separate components on different layers, please send us the Photoshop files. Lettering must be included and should be sized to be no larger than the journal text. Figures should be adjusted in size to fit within the column (80.5 mm), intermediate (112 mm) or the full text width (168 mm). Magnifications should be indicated using a scale bar on the illustration. Image files also must be cropped as close to the actual image as possible. Figure legends: These should be typed in numerical order on a separate sheet.
Figure legends should be provided separately from figures, after the references in the manuscript. Each legend should be a brief overview of the entire figure and must be explicitly referenced. Permission for publishing figures that are taken from other sources or are recognizable photographs of people, requires the permission of the concerned authorities. For previously published figures, permission to reprint must be obtained from the original copyright holder. Usually, this does not include the author(s), but the publisher. Authors (or their assistants) are required to provide these relevant details to the journal. A “patient’s consent to publication” must be signed by the patient or the patient’s legal guardian.
Note: All the figures and tables should be enclosed with the main file.
Manuscript Styling: AMA format
• Commas: Use commas to set off academic degrees, titles, dates: August 14, 1929, etc.
• Hyphens: Hyphenate a compound word that contains a noun and adverb or participle to make an adjective: e.g., decision-making methods. Hyphenate an adjective-noun compound when it falls before the noun it modifies: e.g., upper-class values. Hyphenate a compound adjectival phrase when it precedes the noun it modifies: e.g., end-to-end anastomosis.
• Ellipses: Can be used at the beginning or end of a passage to refer to the material omitted before or after the section.
• Capitalize terms when they refer to specific things such as the East Coast or the Congressional Budget Office. When these terms are generalized, they are included in lowercase.
• Capitalize the title of a person when it comes before the name, but not if it comes after the name.
• In headers and titles, do not capitalize the second part of a hyphenated word if either part is a hyphenated suffix or prefix (e.g., Anti-infective Drugs).
iii. Numbers and Dates
• Numerals should be used to denote numbers: Exceptions being numbers in the beginning of a sentence, title, common fractions; accepted uses include idiomatic expressions and numbers as pronouns.
• Dates: Full dates when written in the text or in references are written “August 21, 2001.”
• Numerals and words are combined by large rounded numbers: For example: “About 5 million people were affected by the famine.”
• Common fractions are usually written as words. A hyphen is inserted in a fraction only when it is used as an adjective: e.g., “a two-thirds majority.”
• Drugs: Use non-proprietary names of drugs, devices, and other products, unless the specific trade name of a drug is directly relevant to the discussion.
• Microorganisms other than viruses: The names of the taxa from the kingdom through the family are set in roman type. The names of taxa at the level of the genus and the below divisions (including subgenus, species, and subspecies) are represented in italics. The names of all taxa down through the genus are written with an initial capital letter, and any may be used alone.
• Acronyms should be written out on first use in the text followed by the abbreviation in parentheses. Subsequently in the text, only the abbreviation is used.
• Clinical and technical terms may have acronyms that are unfamiliar or difficult to remember. Unless these are used more than five times in a manuscript, or are very unwieldy in full expression, they should be written out at each mention.
• Avoid introducing an abbreviation in a subheading. Instead, write the term out and repeat it in the text that follows to introduce the acronym.
• Write the plural form of an acronym without an apostrophe. For example, write “the Master of Business Administration (MBA) program is popular because MBAs command high starting salaries.”
• Names of states, territories, and possessions should be spelled out in full when they used alone. When the name of the same state follows the name of the city, the abbreviation should be used, without periods (e.g., New York, NY). Use postal codes for states only when using ZIP codes.
• Latin abbreviations such as etc, e.g., et al., and i.e. should be used only in references or citations.
• Months are generally not abbreviated.
• Based on American National Standard for Information Sciences-Abbreviation of Titles of Publication, certain words may be abbreviated in titles. Refer to the following list for more details:
• States are spelled out when used alone, but abbreviated when used with cities.
vi. Units of Measure
• Use quantitative values in the International System of Units.
• Units are written in lowercase (kilogram), except for Celsius. Abbreviations are generally written in lower case, but there are exceptions noted in the chapter.
• Use exponents (m2) rather than abbreviations cu and sq.
• SI units are not expressed in plural form; but retain the same expression for plurals.
• Drug doses are expressed in conventional metric mass units (milligrams).
• Quotations must be placed within quotation marks and must include a citation referring the reader to the source document. As a matter of form, quotations should be integrated into the flow of the text.
• Longer quotations, quotes requiring more than 4 type written lines in the text, are formatted as block quotes. These are formatted in a reduced type or font.
• Closing quotation marks are placed outside commas and periods, but inside colons and semicolons. If question marks, dashes, and exclamation marks are a part of the quoted text, they should be placed within the quotation marks.
• Use ellipses to indicate an omission in the quoted material.
• Quotations marks are not used around block quotes, but the block is usually set off from the text by additional spacing above and below the block
• Obvious typical errors in a quotation are usually corrected without making a special notation. Use [sic] to note an unusual word choice, concept, term, or spelling to emphasize that the original word is being quoted faithfully.
• Items are listed numerically in the order of citation within the text.
• Within the text, citations use superscript Arabic numbers that are placed outside periods and commas, and inside colons and semicolons.
• When using the authors’ names in the text, only the surname is to be used. Both names should be used if there are two authors. If there are more than two authors, the first author name and “et al.” must be used (Example: Doe et al. reported on the survey.)
• Medical journals: In reference listings, the names of the journals are to be abbreviated according to the US National Library of Medicine’s current Index Medicus.”(p. 297)
“First authors name*” along with their appropriate academic credentials must be added; separated by a semi-colon “;” which should follow the names and credentials of each of the co-authors.
Start with the Department, University/institution/organization, postal address, state, zip code and country.
Note: For different affiliations of the authors, please represent the numbers as superscript complementing the author’s names in the authors section.
Corresponding author details
Complete information of the corresponding author such as full name, academic degree(s), designation, department, university/organization/institution, postal address, city/counties/provinces/state, zip code, country, telephone, fax, and e-mail should be provided.
Ethical and Legal Considerations
A manuscript intended for submission should adhere to and follow the ethical and legal regulations if required. A cover letter as a declaration of information related to prior or duplicate publication/submission, as well as the originality of the manuscript, and any other information that the authors want to convey to the editor is considered mandatory to complete the submission process. The principal investigator or the corresponding author must confirm that he or she has complete access to the data in the study and takes responsibility for the integrity and the accuracy of the data analysis, as well as the decision to submit the manuscript for publication. The authors should declare that the manuscript has not been published previously, or is under consideration for publication elsewhere, in whole or in part. Apart from the above, ethical considerations, agreement/permission, if any patient or animal is included in the study, that should be clearly mentioned in the manuscript. Conflicts of Interest (COI) Statement
Please fill the ICMJE Conflicts of Interest form which is available at http://www.icmje.org/conflicts-of-interest and send it to us along with the submission. Also, please ensure that a Conflicts of Interest (COI) statement has been added soon after the conclusion and/acknowledgement section.
Acknowledgment of contributions to a research project that does not merit authorship is encouraged for all our journals as per the ICMJE guidelines that state: ‘All others who contributed to the work who are not authors should be named in the acknowledgment, and what they did should be described’. However, it is important that all those who are listed this way, be aware of it.
It is recommended that authors mention their contribution towards the project, indicating clearly how each author has contributed towards the paper.
Order of Authors
The ICMJE guidelines state that the order of authorship should be ‘a joint decision of the co-authors. Authors must be able to explain the reason as to why they have been listed in a particular order’.
*Although there is no limit on the number of authors for most types of manuscripts, for short type of articles, we prefer a maximum of three authors.
Openventio Publishers follows a non-exclusive copyright license as created by Creative Commons Attribution 4.0 International (CC BY 4.0) License term which permits the author to publish, reproduce, distribute, display, translate, and reprint the article in any medium or format, provided the original work is properly cited.
The authors are requested to enclose a copyright transfer statement that they “transfer, assign, or otherwise convey all copyright ownership, including any, and all rights incidental exclusively to the journal, in the event that such work is published by the journal along with their submission”.
Patient(s)/Participant(s) Consent Statement
Please ensure that the consent statement is provided at the end of the manuscript. Authors are requested to kindly retain the signed consent form(s) (if applicable) and shall produce it upon request by our review board/editorial board members.
*Note: Patient consent (for images and photographs in a case study) must not be confused with participant’s consent (approval for involvement in a study, e.g. statistical/observational)
Research Ethics Committee or Institutional Review Board (IRB) Approval
Authors must ensure that only ethical or IRB approved (if applicable) research work is submitted. If concerns regarding the credibility of the article are raised, authors may be required to produce the evidence of ethical research approval by the editors and must be answerable to questions concerning the ethical aspects (such as the concerns of research participants or which methods were employed to minimize the patients or animal sufferings).
Animal Ethics and Welfare GuidelinesManuscripts will be considered for publication only if the detailed work therein:
• Follows international, national, and/or institutional guidelines for humane animal treatment and complies with the relevant legislation;
• Has been approved by the ethics review committee at the institution or practice in which the studies were conducted where such a committee exists;
• For studies using client-owned animals, it demonstrates a high standard (best practice) of veterinary care and involves informed client consent;
• Sign a letter certifying that legal and ethical requirements have been met with regards to the humane treatment of animals described in the study;
• Specify in materials and methods the ethical review committee approval of the process and the international, national, and/or institutional guidelines have been followed.
Animal ethics-based criteria for manuscript rejection
i. Manuscripts and authors that fail to meet the aforementioned requirements;
ii. Studies that involve unnecessary pain, distress, suffering, or lasting harm to animals;
iii. The editor holds the right to reject manuscripts on the basis of ethical or welfare concerns.
Scientific Misconduct Policy
Openventio strongly opposes any scientific misconduct from the authors such as misrepresentation: fabrication, falsification, omission; misappropriation: plagiarism and breach of confidentiality; manipulation, etc.
To strictly avoid such malpractices, we follow an editorial pre-quality analysis procedure before the article proceeds into the peer-review assessment step. During the editorial pre-quality analysis of the manuscript, we examine the submitted articles in two stages:
i. Plagiarism checks using online software;
ii. Ethical and legal statements check such as copyright statement, ethical institutional review board approval statement, informed consent statement, conflicts of interest statement, animal ethics board approval statement, authorship statement, funding source statement, unique data statement, etc.
We encourage the authors to follow the internationally accepted standard guidelines such as Declaration of Helsinki for clinical research type of manuscripts, and the AERA and BERA guidelines for academic research. Ensure that reports of clinical trials cite compliance with the Declaration of Helsinki, Good Clinical Practice, and other relevant guidelines to safeguard the participants. Also, the reports of experiments on, or studies of, animals must cite compliance with the US department of health and human services guide for the care and use of laboratory animals or other relevant guidelines. Any article which does not fulfill the above requirements will be immediately rejected and ceased from further processing by the editorial staff.
*Note: Institutions, grant funders or governing bodies wanting to investigate a suspected research or publication misconduct can contact us at firstname.lastname@example.org
Article submissions can be done via email at email@example.com or through our online submission portal.
Article Processing Charge (APC) and Waiver or Discount Policy
Open Access Model in the recent years has disregarded the practice of charging the readers to view/read the published article by imposing Article Processing Charges (APC) on the authors upon publication of their article. This model has benefited the scientific community with the benefit of viewing and reading articles without any monetary barriers, by contributing towards further investigation or research to promote advancement of science.
Openventio Publishers follow the author pay system so as to cover our production expenses which involves editorial review, double-blinded peer review process, styling, editing, formatting, maintaining, and archiving services. APC is imposed at the beginning of the publication process and its flat rate varies according to the type of article for all our open journals.
Short type articles
*Since the waiver scheme for 2017 has exceeded at this time, we are placing a moratorium on all applications until June 2018.
*Apart from the APC, an additional $127 USD will be levied for language editing, irrespective of the article type.
Our payment options offer the authors the flexibility, security, and the convenience of using our services anywhere and anytime. You can choose to pay via credit card or wire transfer.
Via Credit Card:We accept Visa, MasterCard, American Express, Diners Club, and Discover, and has partnered with payment gateway for your convenience—PayPal. The payment gateway available to you will differ depending on your country and the card you choose to use.
Via Bank Transfer:You can make payments directly into our bank account and email the bank wire transfer receipt to us.
*Please note that payments made through bank transfer or check will be charged $50 USD extra.
Withdrawal & Retraction Policy
For articles withdrawn after the pre-quality editorial assessment (PQA), $127 USD will be imposed as a compensatory charge.
The decision of retraction of a manuscript from an issue or archive is to be decided by an author, corresponding author and coauthors, authors’ institution and any other agency.
The decision to mediate retraction is usually attributed to falsification, fabrication or plagiarism. This notification should be immediately communicated to our journals’ staff or editors by submitting a written and signed formal letter.
If none of the authors agree to publish a signed retraction then the editor may issue a retraction notice on behalf of the journal. Once the article has undergone the requisite formalities, the article will be referred to as “Retracted article” or be prominently labeled as “This Article has been Retracted” which would be mentioned clearly on the top of the online link and on each page of the article.
Retraction should never be used in case of typical unintentional errors; instead they should be corrected appropriately. In some cases, due to errors in calibration or poor instrumentation during the experimentation, the data may result in serious and pervasive errors. In such cases, we suggest that the corresponding author publish a retraction notice and thus, an article to replace the retracted manuscript. *Please note that the APC paid is non-refundable in case of retraction.
Corrections from authors in already published articles will be published with a note of correction, along with the corrected date.
Openventio’s editorial board constitutes expert researchers, clinicians and active academicians who ensure the proper maintenance and effective functioning of journal activities and publication of quality articles. The board comprises of an Editor-in Chief, Associate Editors and Editors who are responsible for supervising the appropriate execution of the journal guidelines, contributing the growth and expansion of a diverse scientific community as a whole. All the editors must declare a no competing/conflict of interest statement with the journal prior to their participation. Decision concerning the acceptance or rejection of the article by the editors must be final, unless there is a need for any further reconsideration.
All articles are subject to the Editor-in- Chief’s approval prior to publication and any decision made will be considered as the final say on the matter. The EIC will serve as the journals' figurehead and is expected to raise the journals’ profile within and outside the community.
• Responsible for establishing the editorial board and supervising the activities of the journal editors.
• Clearly communicating all other editorial policies and standards.
• Establishing a procedure for reconsidering editorial decisions.
• Ensuring that the content published meets the standards of the editorial guidelines and policies of the journal, as stated in the journal’s aim and scope.
• Authorized to reject an article that appears to be plagiarized or may be ghostwritten.
• Should respond promptly to complaints and must ensure the dissolution of unresolved matters.
• Submit at least one article (Research/Review) and one editorial per year, based on his/her area of expertise.
• Help the journal with indexing.
• Coin at least one Special Edition annually and promote the same among colleagues and students to seek their active participation.
Associate editors ensure that the technical quality and soundness of the content is maintained, prior the final verdict of the EIC. Hence, they validate and verify that an article is ready for publication.
• Being attentive to strict deadlines by avoiding the possibility of delaying manuscript process in the anticipation of comments from the editors/ reviewers.
• Expected to be available for guidance and support in crucial situations and contribute towards the journal activities if need be.
• Responsible for maintaining the clarity and accuracy of content before publishing.
• Developing mechanisms to ensure timely publication of accepted manuscripts.
• Treating all authors with fairness, courtesy, objectivity, honesty, and transparency.
• Should respond promptly to complaints or concerns raised by authors, editors or reviewers.
• Collaborate with the EIC in soliciting, selecting, and developing outstanding articles for the journal.
• Reviewing the editorial plan – final draft of articles.
• Share latest news and updates on advancing trends in the scientific community and make it available for the author’s feedback.
• Submit at least one article (Research/Review) and one editorial per year, based on his/ her area of expertise.
Editors are usually assigned the articles following the initial Pre-Quality Editorial Assessment which includes plagiarism check and language editing; however, the editors are expected to be accountable for ensuring that the article meets the journal standards of performance and quality.
• Making editorial decisions with reasonable speed and communicating them in a clear and constructive manner.
• Ensure that the content of the article is factually accurate and conveys its meaning clearly.
• Cross -checking spellings, grammar, figures, tables etc. to make sure that it is relevant to the subject of the article.
• May be required to change, modify, paraphrase or condense the content in order to enhance its quality.
• Expected to make or suggest edits to the content in question.
Peer review is the standard method implemented towards analyzing the quality of a research paper. The quality of peer-review process and critical evaluation undertaken by the board members are the most influential factors towards determining the journals’ reputation and quality standard. Openventio strictly follows a double-blinded peer-review process to uphold the journals’ quality and credibility.
• A potential reviewer should be academically qualified (with a PhD or an equivalent academic degree).
• Reviewers should provide their accurate personal details and professional information, and a just representation of their expertise; this includes verifiable contact information. Impersonation of another expert during the review process will be considered as a serious transgression of law.
• The reviewer should agree to review a manuscript only if he/she has the necessary subject expertise to undertake the evaluation.
• The comments/feedback should be concise and constructive, helping to identify the strengths and weaknesses of the manuscript.
• The assigned reviewers can decline to review a manuscript upon assignment, should there be any prior commitments, health concerns, time constraints or any other related issues.
• Invited reviewers should be considerate enough to confirm their decision or availability to review within 24 hours.
• In case the reviewer is currently employed with the same institution as any of the authors, or have been close collaborators with the author, he/she should not agree to review the corresponding manuscript.
• Reviewers should disclose any competing or conflicts of interest (personal, financial, intellectual, professional, political or religious) to avoid complications and potential bias prior to the review process, and refrain from reviewing such manuscripts.
• Following the first round of the reviewers’ evaluation, he/she may choose whether or not to re-review the revised article.
• The journal must be informed if there is to be any unavoidable situation or delay in the review process.
• In case of unavailability to continue with the review of an assigned manuscript after agreement, reviewers are expected to recommend alternate reviewers to undertake the assignment.
• The reviewer may contact the journal for any missing, unclear or incomplete information during the review process.
• Any suspicion in the identity of the author(s) should be immediately informed.
• Authors may not be contacted directly by the reviewers without the permission of the journal, in any case.
• Reviewers should give a fair chance to the authors to respond to the critiques.
• Refrain from using information obtained during the peer review process for one’s own or another’s advantage.
• Involvement of a third party in the review process, without obtaining permission from the journal will be considered as a serious misconduct.
• It is necessary to provide both general and specific comments in the review assessment form.
• Reviewers must refrain from making derogatory or personal comments in the review feedback.
• Reviewers are expected to recommend acceptance/revision/rejection as a verdict along with their other comments on the manuscript.
• The reviewer’s recommendations are not considered final and are subject to change if the journal receives an adequate set of comments during the editorial review, or from the EIC.
• Reviewers should abstain from suggesting the authors to cite their work in order to increase the citation counts or to enhance the visibility of their own/colleagues’ work.
• If the reviewer himself/herself is the handling editor and is asked to review the same manuscript (in case the reviewer withdraws from the peer review in the middle of the process or is unable to submit the feedback), then he/she must handle the manuscript with transparency, without being under the guise of an anonymous additional reviewer.
• Submit at least one article (Research/Review) and one editorial per year based on his/ her area of expertise.
• All the reviewers participating in the peer review process during the corresponding academic year will be felicitated with an electronic certificate of appreciation during the month of December, every year.
To register yourself as a reviewer with one of our journals, please click on Reviewer Registration.
*Note: Identities of all the reviewers shall remain protected in compliance with our double-blinded peer review policy and shall not be disclosed under any circumstances. Reviewers found to be discourteous or producing late and poor quality reviews will be terminated immediately.
• Open access enables readers all over the world to freely access our published articles by downloading the PDFs, sharing the links etc.
• Students, teachers, researchers, and other professionals may avail the benefits of open access through our website.
• By removing the monetary barriers to access our publications, open access makes it easier for students, teachers, researchers, and practitioners to acquire the information needed for the purpose of learning, teaching, research, and practice in a related field.
• All articles received from the editorial board members are also subject to an unbiased double-blinded peer-review process.
Readers are free to send us their suggestions or queries at firstname.lastname@example.org or via Contact Us